Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pioglitazone for diabetes prevention in impaired glucose tolerance.
DeFronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Ratner RE, Williams K, Stentz FB, Musi N, Reaven PD; ACT NOW Study. DeFronzo RA, et al. Among authors: schwenke dc. N Engl J Med. 2011 Mar 24;364(12):1104-15. doi: 10.1056/NEJMoa1010949. N Engl J Med. 2011. PMID: 21428766 Free article. Clinical Trial.
Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.
DeFronzo RA, Banerji MA, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven P, Schwenke DC, Stentz FD, Tripathy D; ACT NOW Study Group. DeFronzo RA, et al. Among authors: schwenke dc. Diabetologia. 2010 Mar;53(3):435-45. doi: 10.1007/s00125-009-1614-2. Epub 2009 Dec 10. Diabetologia. 2010. PMID: 20012012 Clinical Trial.
Actos Now for the prevention of diabetes (ACT NOW) study.
Defronzo RA, Banerji M, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven PD, Schwenke D, Stentz FB, Tripathy D. Defronzo RA, et al. BMC Endocr Disord. 2009 Jul 29;9:17. doi: 10.1186/1472-6823-9-17. BMC Endocr Disord. 2009. PMID: 19640291 Free PMC article.
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates.
Defronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD; ACT NOW Study. Defronzo RA, et al. Among authors: schwenke dc. Diabetes. 2013 Nov;62(11):3920-6. doi: 10.2337/db13-0265. Epub 2013 Jul 17. Diabetes. 2013. PMID: 23863810 Free PMC article. Clinical Trial.
Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk.
Defronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD, Gastaldelli A; ACT NOW Study. Defronzo RA, et al. Among authors: schwenke dc. Diabetes Care. 2013 Nov;36(11):3607-12. doi: 10.2337/dc13-0520. Epub 2013 Sep 23. Diabetes Care. 2013. PMID: 24062330 Free PMC article.
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW.
Tripathy D, Clement SC, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD, DeFronzo RA. Tripathy D, et al. Among authors: schwenke dc. Diabetes Care. 2014 Jun;37(6):1706-11. doi: 10.2337/dc13-1745. Epub 2014 Apr 4. Diabetes Care. 2014. PMID: 24705615 Free PMC article. Clinical Trial.
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study.
Tripathy D, Cobb JE, Gall W, Adam KP, George T, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Reaven PD, Musi N, Ferrannini E, DeFronzo RA. Tripathy D, et al. Among authors: schwenke dc. J Clin Endocrinol Metab. 2015 May;100(5):1855-62. doi: 10.1210/jc.2014-3824. Epub 2015 Jan 20. J Clin Endocrinol Metab. 2015. PMID: 25603459 Free PMC article. Clinical Trial.
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW.
Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD, DeFronzo RA. Tripathy D, et al. Among authors: schwenke dc. J Clin Endocrinol Metab. 2016 May;101(5):2056-62. doi: 10.1210/jc.2015-4202. Epub 2016 Mar 16. J Clin Endocrinol Metab. 2016. PMID: 26982008 Free PMC article.
Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance.
Espinoza SE, Wang CP, Tripathy D, Clement SC, Schwenke DC, Banerji MA, Bray GA, Buchanan TA, Henry RR, Kitabchi AE, Mudaliar S, Stentz FB, Reaven PD, DeFronzo RA, Musi N. Espinoza SE, et al. Among authors: schwenke dc. Age (Dordr). 2016 Dec;38(5-6):485-493. doi: 10.1007/s11357-016-9946-6. Epub 2016 Sep 1. Age (Dordr). 2016. PMID: 27585671 Free PMC article. Clinical Trial.
Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial.
Bray GA, Smith SR, Banerji MA, Tripathy D, Clement SC, Buchanan TA, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Schwenke DC, Stentz FB, Reaven PD, DeFronzo RA. Bray GA, et al. Among authors: schwenke dc. Diabetes Obes Metab. 2013 Oct;15(10):931-7. doi: 10.1111/dom.12099. Epub 2013 May 7. Diabetes Obes Metab. 2013. PMID: 23551856 Clinical Trial.
97 results